The market is there if they can get their act together:
https://kidney.org.au/nofilter/deloittereport?utm_source=newsletter&utm_medium=email+&utm_campaign=deloitte&_cldee=GvvQgnWdIAeRcZEaXJPHSK1Z6PoaDSXqoRFS8SklzVfnYz_lYDSsOCeLE6kH3xP0&recipientid=contact-be4d77e92348ec118c62002248159d41-bba68da9badb44a1a23f418dc71ea76d&esid=fabcb715-bbb0-ed11-83fe-00224818af37
The Report mentioned is by Deloitte.
I did have concern about the size of their target market quoted in their presentations as not all diabetics have kidney problems. But the test would be good for some as a diagnosis every few years. Once diagnised you would not complete another test. You would simply be tested on your GFR blood test to tell your kidney function.
Ann: PromarkerD application for Australian MBS to be resubmitted, page-38
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.030(3.03%) |
Mkt cap ! $133.5M | |||
| Open | High | Low | Value | Volume |
| 99.0¢ | $1.02 | 99.0¢ | $43.52K | 43.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12500 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 46627 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.01 |
Change
0.030 ( 2.03 %) |
||||
| Open | High | Low | Volume | ||
| $1.01 | $1.02 | $1.00 | 13629 | ||
| Last updated 15.54pm 24/05/2024 ? | |||||
| PIQ (ASX) Chart |